DEUS - ETF AI Analysis
Top Page
Xtrackers Russell US Multifactor ETF (DEUS)
DEUS, the Xtrackers Russell US Multifactor ETF, earns a solid overall rating thanks to several high-quality holdings with strong financial performance and growth prospects, such as Regeneron, United Therapeutics, and Travelers, which bring robust revenue, profitability, and supportive valuations to the portfolio. Some holdings like McKesson and ADM introduce risks through high leverage, weaker margins, and bearish technical signals, and the fund’s concentration in U.S. companies means its results are closely tied to the health of the U.S. economy and market conditions.
DEUS vs. SPDR S&P 500 ETF (SPY)
- AUM
- 296.78M
- Region
- North America
- Expense Ratio
- 0.17%
- Beta
- 0.63
- Issuer
- Xtrackers
- Inception Date
- Nov 24, 2015
- Dividend Yield
- 1.41%
- Asset Class
- Equity
- Index Tracked
- Russell 1000 Comprehensive Factor Index
DEUS Summary
Xtrackers Russell US Multifactor ETF (DEUS) is a fund that invests in many large U.S. companies, following the Russell 1000 Comprehensive Factor Index. It focuses on firms that score well on traits like steady earnings and reasonable prices, across sectors such as industrials, financials, health care, and technology. Well-known holdings include CVS Health and Allstate. Someone might invest in DEUS to get broad, diversified exposure to big U.S. companies with a rules-based approach that aims for smoother returns over time. A key risk is that it still rises and falls with the overall U.S. stock market.
How much will it cost me?
The Xtrackers Russell US Multifactor ETF (DEUS) has an expense ratio of 0.17%, meaning you’ll pay $1.70 per year for every $1,000 invested. This is lower than average for actively managed ETFs because it uses a multifactor strategy while keeping costs relatively low.
What would affect this ETF?
The Xtrackers Russell US Multifactor ETF (DEUS) could benefit from positive trends in the U.S. economy, such as strong growth in large-cap sectors like technology and healthcare, which are key components of the fund. However, it may face challenges from rising interest rates or economic slowdowns, which could negatively impact sectors like financials and consumer cyclical stocks. Additionally, regulatory changes or shifts in market sentiment could influence the performance of its top holdings, such as Cardinal Health and McKesson.
DEUS Top 10 Holdings
DEUS leans into a diversified mix of U.S. large caps, but a few names are doing most of the heavy lifting. NetApp has been a standout, riding strong momentum in cloud and AI, while CF Industries and Travelers add steady support with solid fundamentals despite some recent choppiness. Incyte and Regeneron give the fund a health care tilt, with performance that’s been mixed but generally constructive. On the softer side, financials like Allstate and T. Rowe Price have been lagging, modestly dragging on returns. Overall, the ETF is broadly U.S.-focused with no single sector dominating the story.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 ALL | Allstate | 0.97% | $2.87M | $62.68B | 27.20% | 74Outperform |
 ADM | Archer Daniels Midland | 0.90% | $2.68M | $39.81B | 31.34% | 64Neutral |
 MCK | McKesson | 0.87% | $2.60M | $117.15B | 29.58% | 62Neutral |
 REGN | Regeneron | 0.69% | $2.05M | $81.41B | 38.93% | 78Outperform |
 TRV | Travelers Companies | 0.56% | $1.65M | $81.25B | 48.92% | 78Outperform |
 SPG | Simon Property | 0.54% | $1.61M | $66.47B | 16.24% | 70Outperform |
 CF | Cf Industries Holdings | 0.54% | $1.59M | $18.29B | 45.57% | 72Outperform |
 NTAP | NetApp | 0.50% | $1.49M | $40.03B | 70.69% | 76Outperform |
 TROW | T Rowe Price | 0.51% | $1.51M | $21.54B | -2.11% | 75Outperform |
 EXPD | Expeditors International | 0.50% | $1.48M | $25.47B | 65.67% | 80Outperform |
DEUS Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DEUS, the sentiment is Positive. The current price of 65.93 is above the 20-day moving average (MA) of 64.57, below the 50-day MA of 65.95, and above the 200-day MA of 63.32, indicating a neutral trend. The MACD of -0.03 indicates Negative momentum. The RSI at 60.55 is Neutral, neither overbought nor oversold. The STOCH value of 86.27 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DEUS.
DEUS Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| DEUS | $65.93 | $72.00(9.20% Upside) | $296.78M | 0.17% | 71Outperform |
 IUS | $70.22 | $81.22(15.66% Upside) | $997.04M | 0.19% | 73Outperform |
 INFO | $28.11 | $33.94(20.76% Upside) | $949.56M | 0.35% | 74Outperform |
 PTL | $268.63 | $344.49(28.24% Upside) | $879.10M | 0.09% | 70Neutral |
 SPHB | $139.30 | $188.35(35.21% Upside) | $859.13M | 0.25% | 71Outperform |
 NBCR | $34.11 | $41.97(23.05% Upside) | $850.62M | 0.29% | 73Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DEUS | Xtrackers Russell US Multifactor ETF | 65.93 | 8.91 | 15.63% | |
| IUS | Invesco RAFI Strategic US ETF | 70.22 | 15.34 | 27.96% | |
| INFO | Harbor PanAgora Dynamic Large Cap Core ETF | 28.11 | 4.18 | 17.45% | |
| PTL | Inspire 500 ETF | 268.63 | 20.54 | 8.28% | |
| SPHB | Invesco S&P 500 High Beta ETF | 139.30 | 27.34 | 24.42% | |
| NBCR | Neuberger Berman Core Equity ETF | 34.11 | 3.19 | 10.31% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.